Patent Yard Sign in
Expired Canadian patentCanada

Filling device for a needleless injector cartridge

CA 2207991 C · Owner: Aradigm Corporation · Inventors: Weston, Terence Edward

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A needleless injection dispensing cartridge is filled through its discharge orifice with the drug to be injected by use of an adaptor. The filling means for example a hypodermic syringe, is snapped off of the needleless injector cartridge after use, and the needle remains covered by the adaptor. The adaptor can comprise a pair of sleeves one of which receives the cartridge , and the other of which receives the end of the syringe. Alternatively the , role of the first of these sleeves can be assumed by the body of the cartridge itself.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 13, 1995 and granted August 21, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 13, 2015.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 13, 2017.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 13, 1995
GrantedAugust 21, 2001
Term endedDecember 13, 2015
Patent numberCA 2207991 C
Classification (IPC)A61M5/30 +1 more

Timeline

Timeline From CIPO dates

1996199820002002200420062008201020122014Application filedDec 13, 1995Patent grantedAug 21, 2001Term endedDec 13, 2015

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.